BackSOPHiA Genetics SA Overview

SOPHiA Genetics SA Total Liabilities

Latest total liabilities for SOPH: $110M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$111.31M
82.15% YoYΔ $50.20M vs prior year quarter

Peer average

Loading

SOPHiA Genetics SA Total Liabilities History

Loading

SOPHiA Genetics SA vs. peers: Total Liabilities Comparison

Loading

SOPHiA Genetics SA Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SOPHiA Genetics SA (SOPH) FAQ

SOPHiA Genetics SA posts a total liabilities of $110M as of March 2026. That compares with $61M in the prior-year period — up 82.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SOPHiA Genetics SA's total liabilities was $61M. The latest reading is $110M — a 82.2% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of SOPHiA Genetics SA's financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SOPH's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; SOPHiA Genetics SA's other metric pages and overview cover the third.

Judging SOPHiA Genetics SA against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total liabilities easier to interpret. Start with $110M here, then scan peer and history charts to see if the gap is persistent.